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Abstract
Melissa officinalis (L.) (Lamiaceae), a plant known as the lemon balm, is native to the east Mediterranean region and
west Asia. Also found in tropical countries, such as Brazil, where it is popularly known as “erva-cidreira” or “melissa”,
it is widely used in aqueous- or alcoholic-extract form in the treatment of various disorders. The aim was to investi-
gate in vivo its antigenotoxicity and antimutagenicity, as well as its genotoxic/mutagenic potential through comet and
micronucleus assaying. CF-1 male mice were treated with ethanolic (Mo-EE) (250 or 500 mg/kg) or aqueous
(Mo-AE) (100 mg/kg) solutions of an M. officinalis extract for 2 weeks, prior to treatment with saline or Methyl
methanesulfonate (MMS) doses by intraperitoneal injection. Irrespective of the doses, no genotoxic or mutagenic ef-
fects were observed in blood and bone-marrow samples. Although Mo-EE exerted an antigenotoxic effect on the
blood cells of mice treated with the alkylating agent (MMS) in all the doses, this was not so with Mo-AE. Micronucleus
testing revealed the protector effect of Mo-EE, but only when administered at the highest dose. The implication that
an ethanolic extract of M. officinalis has antigenotoxic/antimutagenic properties is an indication of its medicinal rele-
vance.
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Introduction
Medicinal plants and their derived forms (extracts,
syrups,etc.)havebeenthebasisofmedicaltherapyforcen-
turies. Traditionally used in the treatment of several human
disorders, their pharmacological and therapeutic properties
are attributed to various chemical constituents isolated
from their crude extracts (Pereira et al. 2009). Notwith-
standing, their correct use requires the manipulation of
plants selected for their efficacy and safety, based either on
folk tradition or scientific validation (Tovart, 2009). The
use of herbal infusions to cure various disorders is very
common in Brazilian folk medicine, often replacing mod-
ern forms. Although the diversity of plant species in Brazil
is a potential source of biologically active compounds, the
effects on human health and genetic material are often un-
known. Not all are harmless, some even presenting toxic
and mutagenic substances in their phytochemical composi-
tion (Bresolin and Vargas, 1993; Sá-Ferreira and Vargas,
1999; Fernandes and Vargas, 2003). On the other hand,
there are indications that the protective action on genetic
material can lead, not only to its repair, but also the preser-
vation of its integrity (Berhow et al. 2000; Fernandes and
Vargas, 2003; Souza et al. 2004). Interest in such popular
usage has recently gained strength, through recent knowl-
edge that chemicals, such as proteases and antioxidants
maypreventorreducethedevelopmentofcancerbyblock-
ing genetic damage (Berhow et al. 2000; Hernández-Ce-
ruelos et al. 2002; Souza et al. 2004).
Originally native to the east Mediterranean region
and west Asia, Melissa officinalis (L.) (Lamiaceae) (lemon
balm)isalsoencounteredincertaintropicalcountries,such
asBrazil,whereitispopularlyknownas‘erva-cidreira’and
‘melissa’ (Souza et al. 2004). Aqueous and alcoholic ex-
tracts from the aerial part of Melissa officinalis are tradi-
tionally used in the treatment of fevers and colds, indiges-
tion associated with nervous tension, hyperthyroidism,
depression, mild insomnia, epilepsy, headaches, tooth-
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Research Articleaches, and so on (Carnat et al. 1998; Herodez et al. 2003;
Salah and Jäger, 2005; Dastmalchi et al. 2008). Further-
more, its antioxidant activity has been described by various
authors (Mimica-Dukic et al. 2004; Souza et al. 2004;
Canadanovic-Brunet et al. 2008).
Phytochemical studies carried out with M. officinalis
have demonstrated the numerous constituents, viz., poly-
phenolic compounds (rosmarinic acid, caffeic acid and
protocatechuic acid), essencial oils (citral), monotherpe-
noid aldehides, sesquiterpenes, flavonoids (luteolin) and
tannins (Carnat et al. 1998; Guginski et al. 2009). Pharma-
cological investigation concerning its essential oil has re-
vealed that, besides this being an efficient antibacterial and
antifungal agent (Mimica-Dukic et al. 2004), it is also en-
dowed with intrinsic anxiolytic properties (Pereira et al.
2005). The antioxidant and antitumoral properties are im-
pliedfromaliteraturethatismainlyaddressedtocorecom-
ponents,otherthanextractsorinfusionsperse(Souzaetal.
2004; Pereira et al. 2009).
It is worth while emphasizing that, in many studies,
only the effects of isolated phytochemicals and complete
mixtures in in vitro tests are taken into consideration. In
most cases the antimutagenic action attributed to certain
plants is, in fact, due to intrinsic compounds, mainly flavo-
noids (Czeczot and Kusztelak, 1993; Hernández-Ceruelos
et al. 2002; Gomes-Carneiro et al. 2005).
However,dataconcerningtheactionofcomplexmix-
tures, such as teas and juices of vegetable and fruit origin,
thepredominantformofintake,arescarce,wherebytheim-
portance of their study. Considering the widespread thera-
peutic usage of Melissa officinalis, mainly in south Brazil,
the aim was to investigate the mutagenic and genotoxic ac-
tivities of its aqueous and ethanolic extracts, by way of
micronucleus testing and comet assaying. In their absence,
the antimutagenic and antigenotoxic potential were also in-
vestigated.
Material and Methods
Plant material
Aerial parts of M. officinalis were collected in Grão
Pará, SC, Brazil in September 2008. A voucher specimen
(numberCRI7380)wasdepositedattheHerbariumPe.Dr.
Raulino Reitz, Universidade do Extremo Sul Catarinense,
Criciúma, SC, Brazil. The parts were allowed to dry under
air circulation (40 °C) for 3 days.
Preparation of extracts
The ethanolic extract was obtained according to me-
thodology proposed by the Brazilian Pharmacopoeia (Far-
macopéia Brasileira, 2001). This was prepared by soaking
200 g of dried pharmacogen (ground in a knife mill) in 1 L
of solvent (water-alcohol solution of ethanol 45%) for
about 15 days at room temperature, protected from the
light, with stirring once a day, and no renewal of the liquid
extractor. The liquid product was then gauze-strained and
filtered, to then be completed to a volume of 1000 mL with
the same solvent. The extract was first evaporated to dry-
ness under reduced pressure, whereupon the dry form was
diluted in water, in order to furnish two different doses for
testing (250 and 500 mg/kg) (Müzell, 2006). This aqueous
extract was obtained by infusion of 0.6 g of dry pharma-
cogen in 20 mL of distilled hot water, immediately before
use, its dose (100 mg/kg) being based on the calculation of
total solids.
Phytochemical screening
Phytochemical analysis of flavonoids, tannins, an-
thraquinones, alkaloids, saponins, coumarins and cardiac
glycosides, from the aerial parts of the plant was according
to methods described by Harborn (1998). Thin-layer chro-
matography analysis was according to Wagner and Bladt
(2009). The aluminum chloride colorimetric method was
used for the quantitative determination of flavonoids (Far-
macopéia Brasileira, 2001). Each plant extract in methanol
(0.5 mL of 1:10 g) was separately mixed with 1.5 mL of
methanol,0.5mLof2%aluminumchloride,0.1mLof1M
potassium acetate and 2.8 mL of distilled water. After
standing at room temperature for 30 min, reaction-mixture
absorbance was measured at 425 nm with a biospectro
Model SP-22 UV/Visible spectrophotometer.
Animals and treatments
CF-1 male mice (weighing 40-50 g) were obtained
fromthebreedingcoloniesoftheUniversityofSouthSanta
Catarina, UNESC, Criciúma, SC, Brazil. The animals were
kept in plastic cages in an experimental room under con-
trolled conditions of temperature (22  2 °C), humidity
(55  10%), 12-h light/dark cycles and ad libitum access to
food and water. They were randomized at the beginning of
theexperiment.ThestudydesignwasapprovedbytheAni-
mal Ethical Committee of UNESC (protocol number
043/2008), and the experiments undertaken in accordance
with the ethical principles of the Brazilian College of Ani-
mal Experimentation – COBEA.
The mice were divided into 7 groups, with 5 animals
per group. Methyl methanesulfonate (MMS, Sigma-
Aldrich) was used to induce mutations and DNA damage
for antimutagenic/antigenotoxic evaluation. Just before
use, the MMS was diluted in 0.9% NaCl. The exposure
route was by intraperitoneal (ip) injection (40 mg/kg b.w).
Evaluation of either DNA damage or protection by the
aqueous and ethanolic extracts of M. officinalis, was ac-
cording to protocol developed by Azevedo et al. (2007),
with the following adaptations (Figure 1): The mice in
group 1 received only distilled water (10 mL/kg b.w. per
day by gavage) for 2 weeks prior to treatment with 0.9%
NaCl by intraperitoneal (i.p.) injection. Although they also
received distilled water (10 mL/kg b.w. per day by gavage)
for 2 weeks, those in group 2 were treated with MMS
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thday.Individualsingroups3and
4 received an M. officinalis ethanolic extract (10 mL/kg
b.w. per day by gavage), prepared in two different doses,
250 mg/kg (group 3) and 500 mg/kg (group 4), for 2 weeks
prior to treatment with MMS. Individuals in group 5 re-
ceived only a Melissa officinalis ethanolic extract
(500 mg/kg by gavage) prior to a 0.9% NaCl i.p. injection
on the 15
th day. Individuals in groups 6 and 7 received the
aqueous extract of Melissa officinalis (100 mg/kg),
10 mL/kg b.w. per day by gavage, for 2 weeks prior to a
0.9% NaCl or MMS i.p. injection on the 15
th day. The mice
were killed by cervical dislocation, 24 h after treatment, for
evaluation of micronucleated polychromatic erythrocytes
(MNPCEs) in the bone-marrow. For comet assaying, sam-
plesofperipheralbloodwerecollectedfrommousetail-tips
by a slight incision, 4 h after MMS treatment.
Comet assay
Single-Cell Gel Electrophoresis, or the comet assay,
is a highly sensitive method for assessing DNA damage
formation and repair, both at clinically relevant and low
doses. Alkaline-comet assaying was undertaken as de-
scribed by Singh et al. (1988). Peripheral blood samples
were collected from the tail of each animal in heparinized
microtubes, 4 h after MMS treatment. Briefly, 5 Lo f
whole blood was embedded in a layer consisting of 95 L
of 0.75% low-melting-point agarose gel on frosted slides,
and then immersed in a lysis buffer (2.5M NaCl, 100 mM
EDTA, and 10 mM Tris [pH 10.0-10.5] with freshly added
1% Triton X-100 and 10% dimethyl sulfoxide), for a mini-
mumof1handamaximumofoneweek.Subsequently,the
slides were incubated in a freshly prepared alkaline buffer
(300 mM NaOH and 1 mM EDTA, pH > 13) for 20 min.
The nuclei were electrophoresed for 20 min at 25 V
(0.90 V/cm) and 300 mA, whereupon the alkali was neu-
tralized with 0.4 M Tris (pH 7.5). After neutralization, the
slides were fixed (15% w/v trichloroacetic acid, 5% w/v
zinc sulfate, 5% glycerol), washed in distilled water, and
dried overnight. The gels were re-hydrated for 5 min in dis-
tilledwater,andthenstainedfor15min(37°C)withasolu-
tion containing the following sequence: 34 mL of Solution
B (0.2% w/v ammonium nitrate, 0.2% w/v silver nitrate,
0.5% w/v tungstosilicic acid, 0.15% v/v formaldehyde, 5%
w/v sodium carbonate) and 66 mL of Solution A (5% so-
dium carbonate). The staining was stopped with 1% acetic
acid, whereupon the gels were air-dried (Villela et al.
2006). The visual classification method of Collins et al.
(1997) was applied to assess the extent of DNA damage.
Cells were scored from 0 (undamaged) to 4 (maximally
damaged), according to tail intensity (size and shape), this
resultinginasingleDNAdamagescore(damageindex)for
each sample and, consequently, for each group. Thus, a
damage index (DI) of the group could range from 0 (com-
pletely undamaged) 100 cells (x 0) to 400 (maximum dam-
age) 100 cells (x 4). The percentage of damage frequency
(DF) was calculated for each sample on the basis of the
number of cells with a tail versus those without.
The micronucleus test
Micronucleus assaying was according to the U.S. En-
vironmental Protection Agency Gene-Tox Program (Ma-
vournin et al. 1990). Slides were prepared from smears of
bone-marrow from both femurs, suspended in foetal calf
serum. These were air-dried, xed in methanol, stained in
10% Giemsa and then coded for blind analysis. One thou-
sandpolychromaticerythrocyteswereanalyzedpermouse.
TheproportionofPCEandNCE(normochromaticerythro-
cytes) in 200 erythrocytes/animal was calculated, to detect
possible cytotoxic effects. The slides were scored blindly,
usingalightmicroscopewitha100ximmersionobjective.
Statistical analysis
Variable normality was assessed using the Kolmo-
gorov-Smirnovtest.Micronucleustestingandcometassay-
ing involved multiple pair-wise comparison between
experimental groups and positive and negative controls,
with the Student t-test at a significance level of 0.05. The
statistical package applied was BioEstat 5.0. The percent-
age of reduction in the frequency of MMS induced DNA
damage was calculated according to Azevedo et al. (2003)
and Waters et al. (1990).
Results
The phytochemical analysis of the M. officinalis ex-
tract (Table 1) indicated the presence of fenolic com-
pounds, tannins, flavonoids, alkaloids and coumarins, but
not of other secondary metabolites, such as anthraquinones
and saponins.
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Figure 1 - The antimutagenicity and antigenotoxicity of an Melissa
officinalis extract in mutagen-induced micronulei.According to comet assay results, DNA damage in
both parameters (damage index and frequency) in mouse
peripheral blood, following ingestion of 500 mg/kg of an
ethanol extract (Mo-EE) and 1.000 mg/kg of an aqueous
extract (Mo-AE), both of M. officinalis, during the 15 days
of treatment, presented no statistically significant differ-
ence (Table 2). Thus, it can be deduced that in both treat-
ments, genotoxic effects on mouse peripheral blood cells
were null. When the antigenotoxicity of both was evalu-
ated, a significant decrease in MMS-induced DNA damage
(DIandDF)wasobservedinmicereceiving250mg/kgand
500mg/kgofMo-EE.Thereductionintheformercasewas
19.3%(Studentt-test,p<0.05)forDF,and34.8%(Student
t-test, p < 0.01) for DI, in relation to the positive control
(MMS 40 mg/kg), and in the latter 53.4% (Student t-test,
p < 0.001) and 46.2% (Student t-test, p < 0.05) for DF and
DI, respectively. The analysis of DNA damage after pre-
treatment with the Mo-AE extract and Mo-EE infusion, in-
dicated no diminution in MMS chemically induced DNA
damage.
According to MN testing of mouse bone-marrow
cells the low frequencies of micronucleated cells presumes
the meager effects of Mo-EE 500 mg/kg and Mo-AE pre-
treatments (Table 3), thereby indicating the virtual absence
of mutagenic or cytotoxic effects. In other words, no statis-
tically significant difference in the frequency of MN PCE
or the ratio of PCE to NCE, between the negative control
and the groups that ingested extracts could be detected.
When evaluating antimutagenicity in Mo-EE and Mo-AE,
a significant decrease in the frequency of MMS-induced
MNPCE was observed only in mice that had received
500 mg/kg of Mo-EE (p = 0.05 - Student t-test). Likewise,
for Mo-AE, there was no statistically significant reduction
in the frequency of MN PCE.
Discussion
Over recent years, it has been widely reported that
dietisahighlyimportantfactorintermsofeithercancerin-
duction or prevention. As already known, certain dietary
micronutrients, such as flavonoids, carotenoids and others,
can play an important role in the modulation or prevention
of cancer development (World Cancer Research Fund,
2008). The ingestion of plant extracts with medicinal prop-
erties represents a plausible alternative in the treatment of
various pathological states in economically unprivileged
countries. However, in the absence of a scientific basis,
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Table 1 - Phytochemical screening.
Test Melissa officinalis
Phenolic compounds
W-Ext + KOH 3% +
W-Ext + FeCl3 1% +
Tannins
W-Ext + gelatine -
W-Ext + FeCl3 3% +
Flavonoids qualitative
W-Ext + MgO/HCl +
Flavonoids quantitative UV 425 nm
CH3OH-Ext 0.572
Alkaloids
W-Ext + Mayers Reagent -
W-Ext + Bertrand’s Reagent -
W-Ext + Dragendorff’s Reagent -
W-Ext + Bouchard’s Reagent +
Antraquinones
W-Ext + KOH 3% -
Coumarins
CH3CH2OH-Ext + KOH/UV 365 nm +
Saponins
W-Ext + HCl (persistent foam) -
W-Ext – water extract./ CH3OH-Ext – methanol extract /
CH3CH2OH-Ext – ethanol extract / (-)negative / (+)positive.
Table 2 - Detection of lesions in DNA (mean  SD) using the comet assay (DF and DI) in peripheral blood cells of mice exposed to methyl metha-
nesulfonate (MMS, 40 mg/kg) and different doses of Melissa officinalis.
Treatments Comet assay
Number of animals DF % reduction DI % reduction
Negative Control 5 10.2  2.58 10.2  2.58 -
Positive Control 5 83.8  9.44 134.4  29.03 -
Mo-EE 250 mg + MMS 5 69.6  6.84
a 19.29 91.2  13.84
b 34.78
Mo-EE 500 mg + MMS 5 44.5  15.41
c 53.39 77  36.09
a 46.21
Mo-EE 500 mg + saline 5 10  2.54 13.8  2.68 -
Mo-AE + saline 5 12.4  2.7 14.8  3.42 -
Mo-AE + MMS 5 68.4  20.5 172  101.36 -
SD = standard deviation; DF = damage frequency; DI = damage index; Mo – EE = Eehanol extract of Melissa officinalis; Mo – AE = aqueous extract of
M. officinalis.
aValues differing significantly from positive control, p < 0.05 (Student t-test)
bp < 0.01,
cp < 0.001.such usage may give rise to serious adverse effects (Souza
et al. 2004). An evaluation of the role of plant extracts, in-
fusions and the main relevant phytochemical antigenotoxic
and antimutagenic compounds involved, is essential,
through the evidential participation of the latter in the pre-
vention of cancer and other disorders (Berhow et al. 2000;
Surh and Fergunson, 2003; Patel et al. 2007). In this study,
the efficacy of two different extracts of M. officinalis
against a well-known genotoxic compound, were tested.
The aim was to investigate new potential antigenotoxic
agentsfromnaturalsources,forpossibleuseinprevention.
M. officinalis is invested with compounds with anti-
oxidant, antinociceptive and antitumoral properties (Sousa
etal.2004;Canadanovic-Brunetetal.2008;Guginskietal.
2009; Pereira et al. 2009). However, as to date no intrinsic
antigenotoxic activity has been demonstrated., an investi-
gation was undertaken, not only of this aspect, but also of
possible antimutagenic and antigenotoxic effects against
DNA damage induced by MMS, an alkylating agent.
Through comet assaying, the first and extremely im-
portant observation was the absence of DNA strand breaks,
aswellastheinducedformationofmicronucleiinmicethat
had received two kinds of M. officinalis extract. Further-
more,cometassayingandMNtestingindicatedtheabsence
ofgenotoxicormutagenicpropertiesinethanolicandaque-
ous extracts, respectively. Pereira et al. (2005) and Furtado
et al. (2008, 2010) are alone in evaluating the genotoxic ac-
tivity of a certain compound present in M. officinalis, viz.,
rosmarinic acid (RA). The former showed, through comet
assaying, that in brain and peripheral blood samples from
rats treated with RA and sacrified 3 h later, there were no
significant differences in any of the parameters used to as-
sess DNA damage, in comparison with the vehicle-treated
control group. The second group investigated the capacity
of RA to prevent chemically induced chromosome break-
ageandDNAdamage,usingthesameassaysasinthepres-
ent study, although with V79 cells (Furtado et al. 2010). It
was shown that, although exerting no genotoxic effect, RA
significantly reduced micronucleus frequency and the ex-
tent of DNA damage induced by doxorubicin. With micro-
nucleus assaying, Furtado et al. (2008) evaluated both the
mutagenicandantimutagenicpotentialofRAonperipheral
bloodcellsinSwissmice.Ontheotherhand,mutagenicas-
sayingrevealednoincreaseinmicronucleifrequencyinan-
imals treated with various concentrations of RA, when
compared to negative controls, whereas in treatments with
these concentrations combined with DXR, there was a sig-
nificant reduction in micronucleus frequency compared to
animals treated with DXR alone.
OninvestigatingtheprotectiveeffectofM.officinalis
in peripheral blood cells by comet assaying, and in bone-
marrowPCEbyMNtesting,itwasclearlyindicatedthatan
M.officinalisethanolicextractwasmoreefficientinrevert-
ing the antigenotoxic damage (comet assaying) than anti-
mutagenic damage (MN testing) induced by MMS.
However, as revealed by both test forms, the aqueous ex-
tract obtained from the infusion of M. officinalis in hot wa-
ter (as a tea) was ineffective.
The already described antioxidant activity of M.
officinalis extracts (Mimica-Dukic et al. 2004; Canada-
novic-Brunet et al. 2008; Pereira et al. 2009), has been at-
tributed mainly to intrinsic phenolic compounds. These
form one of the largest and most ubiquitous groups of plant
metabolites,theirantioxidant,antiinflammatory,antimuta-
genic and anticarcinogenic activities currently being of
widespread interest (Atoui et al. 2005; Franke et al. 2005;
Geetha et al. 2005). Pereira et al. (2009) used encephalic
tissue in the thiobarbituric acid reactive substances
(TBARS) assay and determined the quantity of phenolic
compounds in the plant extracts, in order to verify a possi-
ble relationship with antioxidant activity. They found that
an aqueous extract of M. officinalis was the most active
againstTBARSproductioninducedbyallthetestedagents,
when compared with ethanolic and methanolic extracts
therefrom.Interestingly,theinhibitionoflipidperoxidation
bythethreeincreasedwithphenolcontent.However,inthe
1’-1’diphenyl-2’picrylhydrazyl(DPPH)method,thethree
different extracts obtained from this plant (aqueous,
ethanolicandmethanolic)presentedsimilarantioxidantpo-
tential.Furthermore,Mimica-Dukicetal.(2004),whenex-
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Table 3 - Effects of Melissa officinalis pre-treatments (gavage) on MNPCE frequencies (mean  SD) in the bone marrow of mice, following intra-
peritoneal injection with saline or methyl methanesulfonate (MMS) 40 mg/kg.
Treatment Number of analyzed cells PCE/NCE ratio MNPCEs p values
Negative Control 1000 230.6  4.51 3.6  0.89 -
Positive Control 1000 231.8  7.73 5.2  1.79 0.05
a
Mo-EE 250 mg + MMS 1000 233.8  9.42 3.6  1.67 0.09
Mo-EE 500 mg + MMS 1000 239.0  3.46 2.5  2.52 0.05
a
Mo-EE 500 mg + saline 1000 236.8  7.89 3.2  2.28 -
Mo-AE + saline 1000 227.0  5.39 3.2  1.79 -
Mo-AE + MMS 1000 226.4  5.13 6.4  1.67 0.15
Mo-EE=ethanolicextractofMelissaofficinalis;Mo–AE=aqueousextractofM.officinalisPCE=polychromaticerythrocytesNCE=normochromatic
erythrocytes.
aValues differing significantly from positive control (Student t-test).amining the oil of this plant, noted that, besides possessing
high radical scavenging capacity, it exerted outstanding
protectiveactivityinlipidperoxidationprocesses.Thiswas
found to be positively correlated with a mainly mono-
terpene ketone and aldehyde content. These results are in
accordance with data reported by other authors, thereby
demonstrating that the antioxidant activity of certain La-
miaceae species, fruits and vegetables correlated positively
with phenolic compound content (Ivanova et al. 2005;
Katalinic et al. 2006; Pérez-Pérez et al. 2006).
In the present study, the ethanolic extract of M.
officinalis presented both antigenotoxic and antimutagenic
activities. As phenolic compounds have been shown to be
endowed with these antioxidant properties, their involve-
ment can be inferred.
Phenolic compounds are capable of protecting bio-
logical systems in various ways (Edenharder et al. 2002;
Kelly et al. 2003). They have a dual effect on phase I and
phase II enzymes, repressing some (mainly in phase I) and
stimulatingothers(mainlyinphaseII)(Szaeferetal.2004).
Certain flavonoids, such as hesperetin, can selectively in-
hibit human cytochrome P450, thereby reducing the ab-
sorptionoreliminationoftoxiccompounds(Doostdaretal.
2000). Other phenolic compounds, such as limonoids, are
inducers of the detoxifying enzyme gluthatione S-trans-
ferase. The stimulation of detoxifying enzymes can facili-
tate the elimination of toxic compounds, thereby signifi-
cantly affecting the toxic potential of endogenous and
exogenous chemicals (Kelly et al. 2003). However, since
MMS is a directly acting alkylant, thus not requiring meta-
bolic activaton, the antimutagenic activity of M. officinalis
is not due to interaction with activating enzymes (Lima et
al. 2001). Franke et al. (2005), with the aim of evaluating
whether orange juice could reduce DNA damage induced
by MMS in mice, showed that, under their experimental
conditions, this really occurred. The authors showed that
the components of orange juice are biologically effective,
includingintheroleoftargetsfortoxicantsandinmodulat-
ing metabolization/detoxification routes.
It is likely that phenolic compounds can be methyl-
ated by alkylating agents, instead of conjugation enzymes,
thereby protecting reducing DNA from alkylation. MMS
can methylate nucleophilic regions of DNA, as well as
amino acid molecules, especially in nitrogen atoms. The
methylation of phosphate groups accounts for a minor per-
centage of total MMS methylation (< 1%). MMS geno-
toxicity is mediated by base modifications, which weaken
the N-glycosylic bond, thereby leading to depurination/de-
pyrimidination of DNA strands and the appearance of al-
kali-labile abasic sites (AP sites). The removal of AP sites
by AP endonucleases cleaves the DNA adjacent to these
sites, thereby generating DNA strand breaks (Horvathova
et al. 1998; Boiteux and Guillet, 2004; Franke et al. 2005).
To a minor extent, MMS can also act as a weak oxidative
stress inducer, as observed by Horvathova et al. (1998),
who tested the effect of a synthetic antioxidant (Stobadine,
SBT) in this case.
Two assays were undertaken to elucidate the mecha-
nism of antigenotoxic/antimutagenic action in M.
officinalis. An antimutagenic effect, as revealed by MN
testing, could mainly be due to either the diminished induc-
tion of damage or increased repair. Through comet assay-
ing, it was possible to measure the amount of DNA damage
after treatment with a mutagen, thereby indicating whether
an antigenotoxic effect is due to the reduced formation of
primary DNA lesions or not. Herein, it was possible to
show their obvious induction by MMS, as well as to dem-
onstrate that these effects can be reduced by pre-treatment
withanethanolicextract.Ontheotherhand,MNtestingre-
vealedasignificantreductiononlyatthehighestdoseofthe
extract. Consequently, an M. officinalis extract was effec-
tive in preventing MMS-induced DNA lesions. In the pre-
treatment, phenolic compounds maybe competed as target
sites for alkylation, whereas the absence of protection by
the M. officinalis, aqueous extract against the frequency of
DNAlesionsandmutationsinducedbyMMS,couldbedue
to possible interactions among the compounds contained
within the extract itself.
Takentogether,itcanbeinferredthatanethanolicex-
tract of M. officinalis is endowed with antigenotoxic/anti-
mutagenic properties, and its use in pre-treatment dimin-
ishes the induction of DNA damage by an alkylant agent.
Potential differences in antigenotoxic/antimutagenic activ-
ity by the various extracts still need to be clarified.
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